What Will Psychedelics Mean for the Future of Medicine? dmagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dmagazine.com Daily Mail and Mail on Sunday newspapers.
(OTCQB: ALID) is pleased to announce that it has retained the services of IDR Marketing, Inc. to provide public relations strategies, brand awareness, financial and digital marketing services to the Company.
The marketing awareness services provided by IDR will be aimed at maintaining and building the profile of Allied Corp. through traditional press initiatives, advertising directives and social media strategies.
“IDR Marketing has a proven track record of creating quality media and content across multiple platforms, married with wide-scale distribution, to get our story out to the science, health and investment communities. We look forward to working with the company to grow our profile in America. We believe it’s time to deliver our message to existing and prospective shareholders to maximize our value,” said Calum Hughes, CEO and Founder of Allied Corp.
Allied Corp Launches Strategic North American Public Relations and Marketing Campaign globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Allied Moves to Become Leader in Psilocybin Space with Intent to Acquire of Pacific Sun Fungi
Allied Corp.December 24, 2020 GMT
KELOWNA, British Columbia, Dec. 24, 2020 (GLOBE NEWSWIRE) Allied Corp. (“Allied”) (OTCQB: ALID) – an international medical cannabis company focused on creating and providing health solutions to address today’s medical mental health issues is pleased to announce the signing of a letter of intent to acquire the psilocybin company Pacific Sun Fungi (“Pacific Sun”). This further expands upon Allied’s press release of October 20, 2020 communicating the submission of the provisional patent for Allied’s functional mushroom formulation targeting major depression and anxiety.